Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy

Candace B Mainor1, Alison P Duffy2, Kristin L Atkins3

  • 1Department of Medicine, University of Maryland School of Medicine, Baltimore, USA cmainor@umm.edu.

BCR-ABL inhibitors administered in conjunction with chemotherapy have significantly improved outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia but, for patients diagnosed during pregnancy, data on risks to the fetus are limited. We report a woman treated with chemotherapy and imatinib mesylate who delivered a healthy baby at 30 weeks, and we discuss available data.